{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "65219-080",
      "generic_name": "gadoterate meglumine",
      "labeler_name": "Fresenius Kabi USA, LLC",
      "brand_name": "Gadoterate Meglumine",
      "active_ingredients": [
        {
          "name": "GADOTERATE MEGLUMINE",
          "strength": "376.9 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "65219-080-05",
          "description": "10 CARTON in 1 BOX (65219-080-05)  / 1 VIAL in 1 CARTON (65219-080-01)  / 5 mL in 1 VIAL",
          "marketing_start_date": "20220620",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "spl_set_id": [
          "e0655aac-9508-4141-94f5-fcca6af1c41d"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0365219086017",
          "0365219084013",
          "0365219080015",
          "0365219082019"
        ],
        "unii": [
          "L0ND3981AG"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION",
      "spl_id": "f05922b7-99d4-48c7-972a-7966bbbbc3b4",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20220620",
      "product_id": "65219-080_f05922b7-99d4-48c7-972a-7966bbbbc3b4",
      "application_number": "ANDA215304",
      "brand_name_base": "Gadoterate Meglumine",
      "pharm_class": [
        "Gadolinium-based Contrast Agent [EPC]",
        "Magnetic Resonance Contrast Activity [MoA]"
      ]
    }
  ]
}